IL-6R blockade with tocilizumab disrupts pericyte– and tumor cell–driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer
來源 Nature 生命科学13 小時前
內容摘要
This item is a 英语-language original; headline and summary shown as published.
IL-6R blockade with tocilizumab disrupts pericyte– and tumor cell–driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer
本站僅提供標題與摘要索引，完整內容與版權均歸原發布方所有，請點擊原文連結閱讀。
前往原文- 所屬頻道
- 科學
- 所屬地區
- 全球視角
- 原文語種
- 英语
- 條目編號
- science-3aa545af
Comments 0 comments
No comments yet. Be the first.